Prostate cancer secondary prevention

	Prostate cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Prostate Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Staging
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Alternative Therapy
Case Studies
Case #1
Prostate cancer secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Prostate cancer secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Prostate cancer secondary prevention
CDC on Prostate cancer secondary prevention
Prostate cancer secondary prevention in the news
Blogs on Prostate cancer secondary prevention
Directions to Hospitals Treating Prostate cancer
Risk calculators and risk factors for Prostate cancer secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2] Kavya Keerthi Vadlamudi, M.B.B.S.[3]

Overview[edit | edit source]

There are no specific secondary preventive measures available but healthy lifestyle practices may decrease the overall mortality in prostate cancer patients.

Secondary Prevention[edit | edit source]

Despite limited studies, Measures like consuming a healthy diet with lots of vegetables, good fat; Avoiding cured meat and milk products, and choosing lean protein; Avoiding packaged and refined food like sugar, flour; Indulging in rigorous physical activity have known to decrease the progression of prostate cancer and improve the overall health of the patient.^[1]

References[edit | edit source]

↑ Chan JM, Van Blarigan EL, Kenfield SA (2014). "What should we tell prostate cancer patients about (secondary) prevention?". Curr Opin Urol. 24 (3): 318–23. doi:10.1097/MOU.0000000000000049. PMC 4084902. PMID 24625429.

Template:WH Template:WS

[pmid24625429-1] Chan JM, Van Blarigan EL, Kenfield SA (2014). "What should we tell prostate cancer patients about (secondary) prevention?". Curr Opin Urol. 24 (3): 318–23. doi:10.1097/MOU.0000000000000049. PMC 4084902. PMID 24625429.

[1]